GSK snags Japanese approval for first hepatitis B functional cure, Hibsago
GSK has netted the first approval globally for its chronic hepatitis B therapy, bepirovirsen, from Japan’s Ministry of…
GSK hep B drug cures one-fifth of patients in ‘major step’
GSK is pulling back the curtain on the phase 3 success of its chronic hepatitis B drug bepirovirsen,…
GSK hepatitis B drug a long-term opportunity but US bank holds back from upgrading
GSK hepatitis B drug a long-term opportunity but US bank holds back from upgrading Proactive uses images sourced…
GSK hepatitis B drug a long-term opportunity but US bank holds back from upgrading
Citi is holding back from recommending GSK PLC (LSE:GSK, NYSE:GSK) shares despite a significant clinical breakthrough in hepatitis B…
GSK cuts deal with Sino to broaden reach of hepatitis B drug
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…